Rua Bioscience is trading at NZD 0.03, down 7.41%, with the decline unexplained and no verified company-specific catalyst identified.
- NZX listings show no Rua announcements on October 7 or October 8, 2026. The September rights offer remains in progress, but evidence does not establish it as the cause.
- Major U.S. indices showed no material move, leaving broader-market causation unclear; the earlier UK agreement and unrelated macro headlines are not supported explanations.